这个期刊已经大规模撤回多篇文章，值得关注留意

European review for medical and pharmacological sciences，目前影响因子：3.024，目前因为同一种原因（Since this article has been suspected of research misconduct and the corresponding authors did not respond to our request to prove originality of data and figures）已经大规模撤回了多篇文章，肯定会影响相关的名声，所以非常值得关注留意。具体撤稿文章和相关链接如下：

1、Since this article has been suspected of research misconduct and the corresponding authors did not respond to our request to prove originality of data and figures, “The targeted regulation of miR-26a on PTEN-PI3K/AKT signaling pathway in myocardial fibrosis after myocardial infarction, by S. Zhang, R. Cui, published in Eur Rev Med Pharmacol Sci 2018; 22 (2): 523-531–DOI: 10.26355/eurrev_201801_14205–PMID: 29424913” has been withdrawn.

官网撤稿链接：https://www.europeanreview.org/article/22989

2、Since this article has been suspected of research misconduct and the corresponding authors did not respond to our request to prove originality of data and figures, “LncRNA AB073614 promotes tumor migration and invasion by repressing CDKN1A in non-small cell lung cancer, by W.-D. Zhao, B.-X. Zhang, X.-H. Cui, J. Zhang, N. Du, Y.-F. Zhang, published in Eur Rev Med Pharmacol Sci 2019; 23 (13): 5815-5822–DOI: 10.26355/eurrev_201907_18320–PMID: 31298333” has been withdrawn.

官网撤稿链接：https://www.europeanreview.org/article/22197

3、Since this article has been suspected of research misconduct and the corresponding authors did not respond to our request to prove originality of data and figures, “MiR-30 suppresses lung cancer cell 95D epithelial mesenchymal transition and invasion through targeted regulating Snail, by M.-J. Fan, Y.-H. Zhong, W. Shen, K.-F. Yuan, G.-H. Zhao, Y. Zhang, S.-K. Wang, published in Eur Rev Med Pharmacol Sci 2017; 21 (11): 2642-2649–PMID: 28678320” has been withdrawn.

官网撤稿链接：https://www.europeanreview.org/article/22986

4、Since this article has been suspected of research misconduct and the corresponding authors did not respond to our request to prove originality of data and figures, “MiR-16 inhibits pituitary adenoma cell proliferation via the suppression of ERK/MAPK signal pathway, by D.-W. Wang, Y.-Q. Wang, H.-S. Shu, published in Eur Rev Med Pharmacol Sci 2018; 22 (5): 1241-1248–DOI: 10.26355/eurrev_201803_14464–PMID: 29565480” has been withdrawn.

官网撤稿链接：https://www.europeanreview.org/article/22992

5、Since this article has been suspected of research misconduct and the corresponding authors did not respond to our request to prove originality of data and figures, “MiR-143 regulates proliferation and apoptosis of myelocytic leukemia cell HL-60 via modulating ERK1, by B. Song, Y.-J. Tang, W.-G. Zhang, C.-C. Wan, Y. Chen, L.-J. Zhang, published in Eur Rev Med Pharmacol Sci 2018; 22 (11): 3333-3341–DOI: 10.26355/eurrev_201806_15153–PMID: 29917183” has been withdrawn.

官网撤稿链接：https://www.europeanreview.org/article/22994

由于版面问题，上面只是列出了5篇撤稿文章，实际上该期刊撤回来的文章数目远远不止这些，文章作者基本上都是国内的临床医生，遍布国内各城市的三甲医院。为什么要关注留意这个期刊呢？因为之前有不少期刊因为大规模撤稿而被SCI、PubMed踢出去，至于这个期刊会不会被踢就很难讲了，但是名声肯定是大打折扣，甚至被一些单位拉黑。